Twilight Litaka Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Jun ' 14	Mar ' 12	Mar ' 11	Mar ' 10	Mar ' 09

Sources of funds

Owner's fund

Equity share capital

12.39

12.39

10.64

10.64

10.64

Share application money

-

-

7.53

7.53

-

Preference share capital

-

-

-

-

-

Reserves & surplus

-138.85

163.45

126.95

82.23

53.33

Loan funds

Secured loans

201.09

250.86

214.10

158.20

133.31

Unsecured loans

67.60

31.84

30.20

36.99

27.12

Total

142.24

458.54

389.42

295.59

224.40

Uses of funds

Fixed assets

Gross block

120.61

119.32

100.88

84.49

72.24

Less : revaluation reserve

5.55

5.58

5.60

5.61

5.63

Less : accumulated depreciation

37.20

24.80

19.92

17.12

14.05

Net block

77.87

88.94

75.37

61.76

52.56

Capital work-in-progress

-

7.42

7.42

9.83

5.34

Investments

10.72

10.72

10.72

0.04

0.04

Net current assets

Current assets, loans & advances

220.41

438.49

379.21

296.37

221.68

Less : current liabilities & provisions

166.76

87.03

83.29

72.41

55.21

Total net current assets

53.65

351.47

295.92

223.96

166.46

Miscellaneous expenses not written

-

-

-

-

-

Total

142.24

458.54

389.42

295.59

224.40

Notes:

Book value of unquoted investments

10.72

10.72

10.72

0.04

0.04

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

92.94

0.05

23.59

11.60

0.11

Number of equity sharesoutstanding (Lacs)

247.81

247.81

212.81

212.81

212.81